Viewing nowPolycrown Tablet (Policarbophil Calcium)
Calcium Polycarbophil 625mg
Tablet · Prescription medication
Genupharm Co., Ltd.

MFDS item code 201501503 · Approved 2015.03.23 · Insurance code 698002770
Adjunct therapy and symptom relief for chronic constipation and diarrhea (including irritable bowel syndrome)
This medicine is used for the symptoms of chronic constipation, non-specific diarrhea, and the symptoms of constipation and diarrhea that occur in irritable bowel syndrome.
For adults, administer 1,250 mg of Policarbophil Calcium orally 1 to 4 times a day. The recommended initial dosage for adults is 1,250 to 2,500 mg per day, with a possible increase to 5,000 mg per day. This drug shows results within 12 to 72 hours. Do not take it right before bedtime, and ensure at least 1 hour for digestion before going to bed.
For children aged 6 to 12 years, administer 625 mg of Policarbophil Calcium orally 1 to 3 times a day. For children under 6 years, consult a doctor.
This medication should not be used in certain patients. First, those who are allergic to this drug or any of its ingredients should avoid taking it. It is also recommended that individuals with unexplained rectal bleeding do not use this medication. Patients exhibiting severe dehydration symptoms should avoid taking this drug, and caution is needed if one has a condition that makes swallowing food difficult. It is safest for patients who must remain lying down due to risk of reflux to avoid this drug. Those with severely impaired colon or bowel function should refrain from taking this medication. Patients with acute abdominal conditions, intestinal obstruction, or intestinal stricture should avoid using this medication as it may worsen symptoms. Patients with hypercalcemia or those with a history of kidney stones should also abstain from this drug. Caution is necessary for patients with severe kidney failure, especially if not on dialysis, and it should be avoided in cases of severe abdominal pain, nausea, or vomiting. Additionally, those requiring limited calcium intake or currently taking active vitamin D preparations should use it cautiously due to the risk of hypercalcemia. Patients on cardiac glycosides need to be cautious as this medication may enhance the effects of their medicine. Individuals with a history of gastric resection or in a state of low stomach acid may find this drug less effective. Kidney patients who are either on dialysis or have mild kidney issues should also take caution due to the risk of calcium deposition and other side effects. While taking this medication, an allergic reaction such as rash or itching may occur, in which case it should be discontinued immediately. Gastrointestinal symptoms such as nausea, vomiting, constipation, diarrhea, abdominal pain may also arise, and liver function tests may indicate elevated levels. Symptoms of intestinal obstruction, edema, headache, or hematuria have also been reported, so it is critical to consult a healthcare professional if any unusual symptoms occur. When taking this medication, it is essential to swallow it with plenty of water; taking it without water may lead to choking or swelling and present risks. If chest pain, breathing difficulties, or difficulty swallowing occurs, stop taking immediately and consult a doctor or pharmacist. This medication is for symptom relief; if symptoms do not improve after 7 days of use, consult a physician. Monitor for adverse reactions if used over a long term. When taking other medications, it is advisable to space them at least 2 hours apart to avoid absorption interference with this drug. In particular, taking it concurrently with tetracycline or fluoroquinolone antibiotics can reduce absorption, so caution is necessary. There is a risk of hypercalcemia when used with active vitamin D preparations, so be careful when combining them. Taking it with calcium supplements may result in side effects due to excessive calcium. If a patient is on cardiac glycosides, inform healthcare professionals as there may be risks of arrhythmias. Furthermore, taking it with acid secretion inhibitors or antacids may reduce the effectiveness of this drug. Pregnant women or those who could become pregnant should take this medication only when the benefit outweighs the risk, as its safety is not established. The safety in children has not been fully confirmed, so caution is warranted. Elderly patients have an increased risk of hypercalcemia due to diminished kidney function, thus dosage adjustments may be necessary.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to prevent air exposure, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness.
White oval film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCalcium Polycarbophil 625mg
Tablet · Prescription medication
Genupharm Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Heeon Pharmaceutical Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Calcium Polycarbophil 625mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.